Reported Standalone quarterly numbers for Indrayani Biotech are:Net Sales at Rs 7.08 crore in March 2021 up 0% from Rs. 0.00 crore in March 2020.
Quarterly Net Loss at Rs. 2.92 crore in March 2021 down 7175.42% from Rs. 0.04 crore in March 2020.
EBITDA stands negative at Rs. 0.15 crore in March 2021 down 400% from Rs. 0.03 crore in March 2020.
Indrayani Biot shares closed at 10.02 on July 05, 2021 (BSE) and has given 41.93% returns over the last 6 months and 13.61% over the last 12 months.
| Indrayani Biotech | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'21 | Dec'20 | Mar'20 | | Net Sales/Income from operations | 7.08 | 5.81 | -- | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 7.08 | 5.81 | -- | | EXPENDITURE | | Consumption of Raw Materials | 4.82 | 3.05 | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 1.02 | 1.12 | 0.00 | | Depreciation | -0.25 | 0.22 | -- | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 1.53 | 0.71 | 0.03 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.05 | 0.70 | -0.03 | | Other Income | 0.15 | 0.01 | -- | | P/L Before Int., Excpt. Items & Tax | 0.10 | 0.71 | -0.03 | | Interest | 1.00 | 0.35 | 0.01 | | P/L Before Exceptional Items & Tax | -0.91 | 0.35 | -0.04 | | Exceptional Items | -2.01 | -2.10 | -- | | P/L Before Tax | -2.92 | -1.74 | -0.04 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -2.92 | -1.74 | -0.04 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -2.92 | -1.74 | -0.04 | | Equity Share Capital | 34.23 | 34.23 | 3.64 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.85 | -0.51 | -0.11 | | Diluted EPS | -0.85 | -0.51 | -0.11 | | EPS After Extra Ordinary | | Basic EPS | -0.85 | -0.51 | -0.11 | | Diluted EPS | -0.85 | -0.51 | -0.11 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|